Eliabe S Abreu - JoVE Visualize

Showing results (1-10 of 8) with videos related to

Pageof 1

Sort By:

Clinics in Liver Disease|May 16, 2026

Currently Approved and Future Regimens for Metabolic Dysfunction-Associated SteatohepatitisEliabe S Abreu, Mazen Noureddin, Hirokazu Takahashi, et al.

Digestive Diseases and Sciences|April 19, 2025

Obeticholic Acid vs Fibrates as Second-Line Therapy for Primary Biliary Cholangitis: Systematic Review and Meta-AnalysisEliabe S Abreu, Pedro Henrique Reginato, Jorge Ferreira Jasmineiro Pitanga, et al.

Journal of Gastroenterology and Hepatology|September 30, 2025

Efficacy and Safety of Obeticholic Acid as Second-Line Therapy in Primary Biliary Cholangitis: Systematic Review and Meta-AnalysisEliabe S Abreu, Gabriel Prusch Fernandes, Henrique de Carvalho Lacerda, et al.

JHEP Reports : Innovation in Hepatology|March 11, 2026

Efficacy and safety of GLP-1 receptor agonists in MASH with fibrosis: A systematic review and meta-analysisRafael Dos Santos Borges, Eliabe S Abreu, Giovanni Gosch Berton, et al.

Medrxiv : the Preprint Server for Health Sciences|November 24, 2025

Individualized treatment effects of corticosteroids in IgA nephropathyDavid L Hoelscher, Nikolas Ej Schmitz, Leon Niggemeier, et al.

Clinics and Research in Hepatology and Gastroenterology|June 30, 2026

Burden and Distribution of Multidrug-Resistant Bacteria Among Hospitalized Patients with Cirrhosis: A Systematic Review and Meta-AnalysisLeonardo Corrêa Süffert, Enzo Arthur Bruno Pergher, Henrique Steffens de Abreu, et al.

Ebiomedicine|July 14, 2026

Individualised treatment effects of corticosteroids in IgA nephropathyDavid L Hölscher, Nikolas E J Schmitz, Leon Niggemeier, et al.

Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 8, 2026

Updated Global Consensus Recommendations for Risk Stratification, Treatment Initiation, and Response Monitoring in Metabolic Dysfunction-Associated Steatotic Liver DiseaseZobair M Younossi, Markos Kalligeros, Vincent Wai-Sun Wong, et al.

Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:

Pageof 1

Clinics in Liver Disease|May 16, 2026

Currently Approved and Future Regimens for Metabolic Dysfunction-Associated SteatohepatitisEliabe S Abreu, Mazen Noureddin, Hirokazu Takahashi, et al.

Digestive Diseases and Sciences|April 19, 2025

Obeticholic Acid vs Fibrates as Second-Line Therapy for Primary Biliary Cholangitis: Systematic Review and Meta-AnalysisEliabe S Abreu, Pedro Henrique Reginato, Jorge Ferreira Jasmineiro Pitanga, et al.

Journal of Gastroenterology and Hepatology|September 30, 2025

Efficacy and Safety of Obeticholic Acid as Second-Line Therapy in Primary Biliary Cholangitis: Systematic Review and Meta-AnalysisEliabe S Abreu, Gabriel Prusch Fernandes, Henrique de Carvalho Lacerda, et al.

JHEP Reports : Innovation in Hepatology|March 11, 2026

Efficacy and safety of GLP-1 receptor agonists in MASH with fibrosis: A systematic review and meta-analysisRafael Dos Santos Borges, Eliabe S Abreu, Giovanni Gosch Berton, et al.

Medrxiv : the Preprint Server for Health Sciences|November 24, 2025

Individualized treatment effects of corticosteroids in IgA nephropathyDavid L Hoelscher, Nikolas Ej Schmitz, Leon Niggemeier, et al.

Clinics and Research in Hepatology and Gastroenterology|June 30, 2026

Burden and Distribution of Multidrug-Resistant Bacteria Among Hospitalized Patients with Cirrhosis: A Systematic Review and Meta-AnalysisLeonardo Corrêa Süffert, Enzo Arthur Bruno Pergher, Henrique Steffens de Abreu, et al.

Ebiomedicine|July 14, 2026

Individualised treatment effects of corticosteroids in IgA nephropathyDavid L Hölscher, Nikolas E J Schmitz, Leon Niggemeier, et al.

Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 8, 2026

Updated Global Consensus Recommendations for Risk Stratification, Treatment Initiation, and Response Monitoring in Metabolic Dysfunction-Associated Steatotic Liver DiseaseZobair M Younossi, Markos Kalligeros, Vincent Wai-Sun Wong, et al.

Pageof 1